AU2002217212A1 - Method for preparing a human monoclonal antibody, fragments thereof or antibodies comprising such fragments, resulting antibodies and use thereof - Google Patents

Method for preparing a human monoclonal antibody, fragments thereof or antibodies comprising such fragments, resulting antibodies and use thereof

Info

Publication number
AU2002217212A1
AU2002217212A1 AU2002217212A AU1721202A AU2002217212A1 AU 2002217212 A1 AU2002217212 A1 AU 2002217212A1 AU 2002217212 A AU2002217212 A AU 2002217212A AU 1721202 A AU1721202 A AU 1721202A AU 2002217212 A1 AU2002217212 A1 AU 2002217212A1
Authority
AU
Australia
Prior art keywords
fragments
antibodies
preparing
monoclonal antibody
human monoclonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002217212A
Other languages
English (en)
Inventor
Herve Bazin
Dominique Latinne
Jacques Noury
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Technopharm SARL
Original Assignee
Technopharm SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technopharm SARL filed Critical Technopharm SARL
Publication of AU2002217212A1 publication Critical patent/AU2002217212A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU2002217212A 2000-12-07 2001-12-07 Method for preparing a human monoclonal antibody, fragments thereof or antibodies comprising such fragments, resulting antibodies and use thereof Abandoned AU2002217212A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0015927 2000-12-07
FR0015927A FR2817875B1 (fr) 2000-12-07 2000-12-07 Procede de preparation d'un anticorps monoclonal humain, de fragments de celui-ci ou d'anticorps comprenant de tels fragments, les anticorps ainsi obtenus et leur utilisation
PCT/FR2001/003881 WO2002046233A1 (fr) 2000-12-07 2001-12-07 Procede de preparation d'un anticorps monoclonal humain, de fragments de celui-ci ou d'anticorps comprenant de tels fragments, les anticorps ainsi obtenus et leur utilisation

Publications (1)

Publication Number Publication Date
AU2002217212A1 true AU2002217212A1 (en) 2002-06-18

Family

ID=8857377

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002217212A Abandoned AU2002217212A1 (en) 2000-12-07 2001-12-07 Method for preparing a human monoclonal antibody, fragments thereof or antibodies comprising such fragments, resulting antibodies and use thereof

Country Status (3)

Country Link
AU (1) AU2002217212A1 (fr)
FR (1) FR2817875B1 (fr)
WO (1) WO2002046233A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101537180B (zh) 2002-07-18 2016-02-10 莫鲁斯有限公司 抗体混合物的重组生产
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
GB2398783A (en) 2003-02-26 2004-09-01 Antonio Lanzavecchia A method for producing immortalised human B memory lymphocytes
ES2408582T3 (es) * 2003-05-30 2013-06-21 Merus B.V. Biblioteca de Fab para la preparación de una mezcla de anticuerpos
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
DK1737971T3 (da) 2004-01-20 2017-11-13 Merus Nv Blandinger af bindingsproteiner
PL1974020T3 (pl) 2005-12-16 2011-11-30 Ribovax Biotechnologies Sa Sposoby uzyskiwania unieśmiertelnionych komórek wydzielających przeciwciała
EA023179B1 (ru) 2009-08-13 2016-05-31 Круселл Холланд Б.В. Антитела против респираторного синцитиального вируса (pcb) и способы их применения
US9260517B2 (en) 2009-11-17 2016-02-16 Musc Foundation For Research Development Human monoclonal antibodies to human nucleolin
MX343298B (es) 2010-07-09 2016-11-01 Crucell Holland Bv Anticuerpos contra el virus sincitial respiratorio (rsv) humano y metodos de uso.
PT2838918T (pt) 2012-04-20 2019-08-23 Merus Nv Métodos e meios para a produção de moléculas heterrodiméricas do tipo ig
JP7075898B2 (ja) * 2017-01-16 2022-05-26 株式会社カネカ Ｂ細胞集団の製造方法、及びそれを用いたモノクローナル抗体の製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3167442D1 (en) * 1980-07-07 1985-01-10 Nat Res Dev Improvements in or relating to cell lines
US5811248A (en) * 1986-03-31 1998-09-22 Charter Ventures Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof

Also Published As

Publication number Publication date
FR2817875B1 (fr) 2005-03-18
WO2002046233A1 (fr) 2002-06-13
FR2817875A1 (fr) 2002-06-14

Similar Documents

Publication Publication Date Title
AU2002338015A1 (en) Human CDR-grafted antibodies and antibody fragments thereof
AU1462300A (en) Human pan-hcv human monoclonal antibodies
AU2001268855A1 (en) Single-domain antigen-binding antibody fragments derived from llama antibodies
AU1704099A (en) Monoclonal human natural antibodies
AU2002220843A1 (en) Humanised antibodies and uses thereof
AU2002359851A1 (en) Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them
AU3596599A (en) Method for producing antibody fragments
ZA200207589B (en) Multivalent antibodies and uses therefor. Multivalent antibodies and uses thereof.
AU2001256325A1 (en) Human and humanized fap-alpha-specific antibodies
AU2001289145A1 (en) Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof
AU6266899A (en) Methods for producing human tumor antigen specific antibodies
IL206832A0 (en) Antibodies binding an 161p2f10b epitope and uses thereof
AU2002313767A1 (en) Porcine leptin protein, antisense and antibody
IL152725A0 (en) Human receptor proteins, related reagents and methods
AU7676300A (en) Human anti-adipocyte monoclonal antibodies and their use
AU2002217212A1 (en) Method for preparing a human monoclonal antibody, fragments thereof or antibodies comprising such fragments, resulting antibodies and use thereof
AU5441000A (en) Human monoclonal antibody
HUP9702359A3 (en) Monoclonal antibody, method of preparing a monoclonal antibody, and pharmaceutical composition and a diagnostic reagent comprising the monoclonal antibody
AU7960600A (en) Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit
AU2003260513A1 (en) Polyclonal antibodies, preparation method thereof and use of same
AU2001255537A1 (en) Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
EP1380646A4 (fr) Anticorps monoclonal reconnaissant l'acetyllysine et son procede de production
AU2001284899A1 (en) Methods and universal monoclonal antibody array
AU2001245552A1 (en) Transcutaneous immunization for large particulate antigens
AU2002221893A1 (en) Method for accessing services and the inspection thereof, making use of a mobileterminal